 SOUTH SAN FRANCISCO, Calif., Feb. 09, 2022 GLOBE NEWSWIRE -- Harpoon Therapeutics, Inc. NASDAQ: HARP, a clinical-stage immunotherapy company developing novel T cell engagers, today announced that management will participate in a virtual fireside chat at the 11th Annual SVB Leerink Global Healthcare Conference. The discussion will take place on Wednesday, February 16, 2022 at 5 p.m. ET 2 p.m. PT. 